Wang · The American journal of clinical nutrition 2024 · systematic review and meta-analysis of RCTs · n=27 RCTs (1278 participants)

Impact of the ketogenic diet as a dietary approach on cardiovascular disease risk factors: a meta-analysis of randomized clinical trials.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of randomized controlled trials

PubMed 39097343 · doi:10.1016/j.ajcnut.2024.04.021 · record verified 2026-08-26

What was done

Authors conducted a systematic review and meta-analysis (PROSPERO CRD42023491853) searching PubMed, Web of Science, EMBASE, and Cochrane Library for randomized controlled trials comparing ketogenic diets with control diets. Fixed- and random-effects models were used to calculate mean differences (MD) and 95% confidence intervals (CIs) for changes in cardiovascular disease risk factors.

What was found

Across 27 RCTs (n = 1,278), ketogenic diets significantly increased: - Total cholesterol: MD 0.36 mmol/L (95% CI: 0.15 to 0.57; I² = 85.1%) - LDL cholesterol: MD 0.35 mmol/L (95% CI: 0.20 to 0.50; I² = 73.9%) - HDL cholesterol: MD 0.16 mmol/L (95% CI: 0.09 to 0.23; I² = 86.7%) Ketogenic diets significantly decreased: - Triglycerides: MD -0.20 mmol/L (95% CI: -0.29 to -0.11; I² = 72.2%) - Blood glucose: MD -0.18 mmol/L (95% CI: -0.33 to -0.02; I² = 76.4%) - Blood insulin: MD -8.32 pmol/L (95% CI: -14.52 to -2.12; I² = 81.5%) - Diastolic blood pressure: MD -1.41 mmHg (95% CI: -2.57 to -0.26; I² = 49.1%) - Body weight: MD -2.59 kg (95% CI: -3.90 to -1.28; I² = 87.4%) - Body mass index: MD -1.59 kg/m² (95% CI: -2.32 to -0.86; I² = 84.5%)

Why it matters

This meta-analysis highlights the conflicting cardiovascular risk profile of ketogenic diets: while they improve glycemic markers, weight, and triglycerides, they simultaneously elevate circulating atherogenic lipoproteins (total and LDL cholesterol).

Limits

High statistical heterogeneity (I² > 70% for most outcomes) was present throughout the meta-analysis. The abstract does not specify intervention durations, the dietary composition of the control groups, baseline health status of participants, or hard cardiovascular endpoints (e.g., major adverse cardiovascular events or mortality).

Cited by